High-efficiency nanotheranostic
agents with multimodal imaging
guidance have attracted considerable interest in the field of cancer
therapy. Herein, novel silver-decorated bismuth-based heterostructured
polyvinyl pyrrolidone nanoparticles (NPs) with good biocompatibility
(Bi-Ag@PVP NPs) were synthesized for accurate theranostic treatment,
which can integrate computed tomography (CT)/photoacoustic (PA) imaging
and photodynamic therapy/photothermal therapy (PDT/PTT) into one platform.
The Bi-Ag@PVP NPs can enhance light absorption and achieve a better
photothermal effect than bismuth NPs. Moreover, after irradiation
under an 808 nm laser, the Bi-Ag@PVP NPs can efficiently induce the
generation of reactive oxygen species (ROS), thereby synergizing PDT/PTT
to exert an efficient tumor ablation effect both in vitro and in vivo.
Furthermore, Bi-Ag@PVP NPs can also be employed to perform enhanced
CT/PA imaging because of their high X-ray absorption attenuation and
enhanced photothermal conversion. Thus, they can be utilized as a
highly effective CT/PA imaging-guided nanotheranostic agent. In addition,
an excellent antibacterial effect was achieved. After irradiation
under an 808 nm laser, the Bi-Ag@PVP NPs can destroy the integrity
of
Escherichia coli
, thereby inhibiting
E. coli
growth, which can minimize the risk of infection
during cancer therapy. In conclusion, our study provides a novel nanotheranostic
platform that can achieve CT/PA-guided PDT/PTT synergistic therapy
and have potential antibacterial properties. Thus, this work provides
an effective strategy for further broad clinical application prospects.